2026 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium

---

LIVE

Wednesday, May 6, 2026, 7:30 AM - Thursday, May 7, 2026, 5:30 PM, MD Anderson - Onstead Auditorium, Houston, TX


AMA PRA Category 1 Credits™ (13.00 hours), Non-Physician Attendance (13.00 hours)

Myelodysplastic Syndromes (MDS) remain a major challenge in hematologic oncology, with effective treatment hinging on deeper insights into stem cell biology under both normal and stress conditions. The upcoming MDS symposium will bring together international experts in hematopoiesis and MDS to exchange knowledge, spark new ideas, and accelerate progress in molecular research and therapeutic innovation. By fostering collaboration across disciplines, this event aims to advance our understanding of MDS and improve care for patients affected by this complex disease.

1. Examine the cellular and molecular processes that regulate hematopoietic stem cell function under normal and stress-induced conditions, and their role in the development of Myelodysplastic Syndromes (MDS).
2. Assess both established and novel therapeutic approaches for MDS in light of recent advances in hematopoietic stem cell biology.
3. Utilize current insights into MDS pathobiology to interpret diagnostic data and evaluate prognostic indicators, including molecular profiles, to enhance clinical decision-making and patient care.
4. Apply emerging insights from international experts in stem cell biology and myelodysplastic syndromes (MDS) to enhance interdisciplinary collaboration, inform strategic clinical research initiatives, and drive innovation in therapeutic approaches aimed at improving patient outcomes in hematologic oncology.

On-site registration for the 2026 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium, will open at 7:00 AM on Wednesday, May 6, 2026 at the Onstead Auditorium located in the Mitchell Building (BSRB) Floor 3, 6767 Bertner Avenue.

The symposium will begin with opening remarks at 8:20 AM and will adjourn for the day at 5:00 PM. The symposium will reconvene on Thursday, May 7, 2026 at 8:30 AM and adjourn at 5:30 PM. Advanced registration is encouraged as space and materials are limited. 

The deadline for advanced registration is Sunday, May 3, 2026

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check made payable to: The University of Texas MD Anderson Cancer Center (payable through U.S. banks only)

Mail to: 

Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
 P.O. Box 301407
 Houston, Texas 77230-1407

Telephone registrations are not accepted

When registering online a receipt (confirmation) will be automatically emailed to the e-mail address you list on the registration form.

Refund/Cancellation Policy The registration fee, minus a $15.00 administration-handling fee, is refundable if a written request is received on or before Monday, April 13, 2026.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of CPE, is limited to the registration fee.  CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information, contact CPE, at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Special Assistance Contact CPE, at 713-792-2223 or toll free at 866-849-5866 if you have any ADA accommodation needs.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 13 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 

Hotel Options: 

Houston Marriott Medical Center
6580 Fannin Street
Houston TX, 77030
713-796-0080
Room Rate:  Varies

Hilton Houston Plaza/Medical Center
6633 Travis Street
Houston TX  77030
713-313-4000
Room Rate:  Varies

DoubleTree by Hilton Houston Medical Center Hotel & Suites
6800 Main Street
Houston, TX  77030
713-528-7744
Rom Rate:  Varies

Hilton Garden Inn Houston Medical Center
6840 Almeda Rd.
Houston, Texas 77030
346-433-8200
Rom Rate:  Varies

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.